Featured News

Selective publication bias in top psychiatry journals was not explained by the quality of the studies, but by financial ties to pharma.

New research by Jim van Os and Peter Groot finds that using hyperbolic tapering to discontinue antidepressants reduces withdrawal effects.

Reduced brain volumes due to SSRI exposure in pregnancy was not explained by maternal depression alone.

Males taking antidepressants were at 100 times the risk of erectile dysfunction compared with the healthy population and more than three times the risk even after controlling for other variables.

Response and remission rates were the same in the drug versus placebo groups, and Lexapro increased suicidality sixfold.

A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

Researchers find that SSRIs increase suicide attempts up to age 24, and have no preventative effect at any age, even for those at high risk of suicide.

Post-SSRI sexual dysfunction (PSSD) may be a common adverse effect of antidepressants. Researchers are now attempting to understand the neurobiology behind it.

The initial study, which has been used to promote antidepressants, employed outcome switching to hide poor results.

In a study of people with borderline personality disorder, only ADHD stimulants were associated with a decrease in suicide.

Robin Williams had "therapeutic" levels of the tetra-cyclic antidepressant mirtazapine in his blood at the time of his suicide, according to the coroner's report...

Researchers can’t predict the 15% who benefit from antidepressants, and the other 85% are unnecessarily exposed to the harms of the drugs.

A new research article asserts that the overuse of psychiatric drugs may create neurobiological changes that hamper long-term mental health recovery.

People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.

New guidance for primary care doctors in the UK on antidepressant discontinuation acknowledges severe and long-lasting withdrawal symptoms.

The antipsychotic clozapine, considered the “gold-standard” treatment for psychosis, was found to increase the risk of blood and lymph system cancers.

For those with severe depression, inpatient CBT was effective but the adding antidepressants did not improve treatment outcomes.

Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.

Researchers find that adverse effects often last over a year, with many users experiencing substantial life changes.

Moncrieff et al. respond to the contradictory and, in some cases, false concerns raised by these critics of their serotonin review.

A new Cochrane review details the lack of evidence for antidepressants in the treatment of chronic pain.

MIA’s Hannah Emerson interviews Comas-Díaz on the need for culturally competent care in a medicalized and individualistic society.

MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.

Genetic testing may help reduce the length of time people experience the harmful effects of antidepressant drugs, but it is not helpful for predicting efficacy.

Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.